GlassScriptPhysician profile
Anthony P Baron
NPI 1184621336
$3,885.91
in general payments reported to CMS, 2019-2025
16 companies · $580 in 2025
The $580 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $855 · 2020: $503 · 2021: $378 · 2022: $448 · 2023: $507 · 2024: $615 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350 · Education: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.91 |
| Education | $351.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,034.35 | 2019-2025 | Tremfya, Simponi Aria, Remicade |
| Amgen INC. | $484.66 | 2019-2025 | Otezla, Otezla, Enbrel |
| Ucb, INC. | $195.21 | 2020-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $182.58 | 2019-2025 | |
| Glaxosmithkline, LLC. | $164.47 | 2019-2025 | Benlysta |
| Lilly USA, LLC | $162.18 | 2019-2024 | Taltz, Olumiant |
| Pfizer INC. | $152.92 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $146.70 | 2019-2025 | Orencia |
| Abbvie INC. | $112.51 | 2019-2025 | |
| Genentech USA, INC. | $76.76 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $59.35 | 2019 | |
| Sobi, INC | $30.36 | 2019-2020 | |
| Horizon Therapeutics Plc | $26.00 | 2023 | |
| Celgene Corporation | $22.87 | 2019 | |
| Boston Scientific Corporation | $17.95 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Baron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.